Vol. 25, No. 2, December 2021
In conversation with IAVI founder Seth Berkley and CEO Mark Feinberg.
A timeline of major milestones in the decades-long effort to develop an HIV vaccine.
After four decades of HIV research, the field seeks to make progress against one of the most difficult pathogens vaccine researchers have ever faced.
Stanley Plotkin discusses the greatest progress in vaccine development in more than half a century and the lingering barriers to an effective HIV vaccine.
COVID-19 has made stark inequities in global access to vaccines, drugs, and diagnostics more visible and alarming than ever.
1 December 2021
Mark Feinberg, Nina Russell, Robin Shattock, Karie Youngdahl
Professor Anatoli Kamali & Dr. Eugene Ruzagira
Kenneth Katumbe, Ph.D. candidate & research assistant, UPTAKE study, MRC/UVRI & LSHTM Uganda Research Unit
Maryam Mahdi, associate editor, The Medicine Maker
Winifred Ikilai, HIV prevention advocate and public health practitioner, National Forum of People Living with HIV & AIDS Networks, Uganda